Impacts of RNAi silencing on the CD105 and Ki67 gene expression in ovarian cancer OVCAR3 cell lines

GUO Hai-rong WANG Xiao-yan HE Shuai LIU Ping*

doi:10.16098/j.issn.0529-1356.2016.04.011

PDF(374 KB)

Acta Anatomica Sinica ›› 2016, Vol. 47 ›› Issue (4) : 502-506. DOI: 10.16098/j.issn.0529-1356.2016.04.011

Cancer Biology

Impacts of RNAi silencing on the CD105 and Ki67 gene expression in ovarian cancer OVCAR3 cell lines

GUO Hai-rong¹WANG Xiao-yan¹ HE Shuai²LIU Ping ^1*

Author information +

History +

Abstract

Objective To detect changes of the CD105 and Ki67 gene expression and to determine the effect of gene silence on OVCARs cells transfected these gene sequences by liposome lipofectamine TM2000 respectively. Methods OVCAR3 were transfected with siRNA of CD105-siRNA group, Ki67-siRNA group and negative control groups in vitro respectively. The expressions of CD105mRNA, Ki67mRNA and their proteins were detected with Real-time PCR and Western blotting. Results The intensities of relative expressions for both CD105 mRNA and Ki 67mRNA were significantly lower in both siRNA-CD105 transfected and siRNA-Ki67-transfected OVCARs than those in control groups(P<0.001). Conclusion CD105-siRNA and Ki67-siRNA can specifically inhibit CD105, Ki67 gene expression levels in ovarian cancer OVCAR3 cells and lowered their mRNA and protein expression.

Key words

CD105 / Ki67 / Real-time PCR / Western blotting / Human

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

GUO Hai-rong WANG Xiao-yan HE Shuai LIU Ping. Impacts of RNAi silencing on the CD105 and Ki67 gene expression in ovarian cancer OVCAR3 cell lines[J]. Acta Anatomica Sinica. 2016, 47(4): 502-506 https://doi.org/10.16098/j.issn.0529-1356.2016.04.011

References

［1］Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012［J］. CAA Cancer J Clin,2012, 62(1):10-29.

［2］Feng XN，Yi TT.Expression and clinical significance of CD105 in epithelial ovarian cancer［J］.Heilongjiang Medicing and Pharmacy，2013,36（6）：17-18. (in Chinese)

冯晓娜，衣甜甜.血管内皮增殖标志物CD105在上皮性卵巢癌血清中的表达水平及意义［J］.黑龙江医药科学，2013,36（6）：17-18.

［3］Kuhn E,Kurman RJ,Sehdev AS,et al.Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma ［J］.Int J Gynecol Pathol,2012,31(5):416-422

［4］Liu P, Sun YL, Du J, et al. CD105/Ki67 co-expression correlates with tumor progression and poor prognosis in epithelial ovarian cancer［J］. Int J Gynecol Cancer, 2012, 22(4):586-592.

［5］Perez-Gómez E, Del Castillo G, Juan Francisco S, et al. The role of the TGF-β coreceptor endoglin in cancer［J］. Scientific World Journal, 2010, 10:2367-2384.

［6］Marioni G, Staffieri A, Manzato E, et al. A higher CD105-assessed microvessel density and worse prognosis in elderly patients with laryngeal carcinoma［J］.Arch Otolaryngol Head Neck Surg, 2011, 137(2):175-180.

［7］Nieman KM,Kenny HA,Penicka CV,et al.Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth［J］.Nat Med,2011,17(11):1498-1503.

［8］Vaughan S,Coward JI,Bast RC,et al.Rethinking ovarian cancer: recommendations for improving outcomes ［J］.Nat Rev Cancer,2011,11(10):719-725.

［9］Zillhardt M,Park SM,Romero IL,et al.Foretinib (GSK 1363089),an orally available multikinase inhibitor of c-Met and VEGFR-2,blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis ［J］.Clin Cancer Res,2011,17(12):4042-4051.

［10］Senol EP, Tasdelen I, Adim SB, et al. A comparison of Ki 67 proliferative index in primary tumor and axillary metastatic lymph nodes with length of survival in patients with breast cancer［J］. Bratisl Lek Listy, 2013, 114(11):645-649.

［11］McCall CM, Shi C, Cornish TC, et al. Grading of welldifferentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate［J］. Am J Surg Pathol, 2013,37(11):1671-1677.

［12］Heim S, Beschorner R, Mittelbronn M, et al. Increasedmitotic and proliferative activity are associatedwith worse prognosis in papillary tumors of thepineal region［J］.Am J Surg Pathol, 2014, 38(1):106-110.

［13］Gu JX,Zhang ZhX. Relationship between CD105 and malignant tumor ［J］.Contemporary Medicine,2015,21（12）：16-17. (in Chinese)

顾金霞，张振新.CD105与恶性肿瘤的关系［J］.当代医学，2015,21（12）：16-17.